A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strains
about
Evolution of H3N2 influenza virus in a guinea pig modelGenetic diversity of hemagglutinin gene of A(H1N1)pdm09 influenza strains isolated in Taiwan and its potential impact on HA-neutralizing epitope interactionInfectious disease modeling methods as tools for informing response to novel influenza viruses of unknown pandemic potential.Genetic structure of human A/H1N1 and A/H3N2 influenza virus on Corsica Island: phylogenetic analysis and vaccine strain match, 2006-2010Understanding original antigenic sin in influenza with a dynamical systemPredicting Fixation Tendencies of the H3N2 Influenza Virus by Free Energy Calculation.Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 seasonIntegrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Post-vaccination Sera.Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 VirusesProteinquakes in the evolution of influenza virus hemagglutinin (A/H1N1) under opposing migration and vaccination pressures.The antigenic evolution of influenza: drift or thrift?Simulation of B cell affinity maturation explains enhanced antibody cross-reactivity induced by the polyvalent malaria vaccine AMA1.Antigenic cartography of H1N1 influenza viruses using sequence-based antigenic distance calculation.Oligomerization of bacterially expressed H1N1 recombinant hemagglutinin contributes to protection against viral challenge
P2860
Q28742283-D335FCF8-F0A9-49D0-A776-B76E0AC16DE0Q30357709-3B836E43-9E68-48D4-ACA9-ACFFA7CCE620Q30373735-A7EC8D9B-C8B9-42BA-BDC6-92C4BBCA216AQ30407318-43108D2F-F033-4B0C-A114-4C83D59CEF6CQ34012816-9FBCB2CF-DB44-4D5B-A760-B46A884E889DQ35052511-791A1084-383C-437A-8BC2-74B4FB16E18BQ36286276-BF92A76C-8F3A-4F04-BDEC-85544FADBC6CQ37114545-3319BA1E-2708-4FDC-9F55-11A678880418Q38415770-60CC6B6B-4D44-4774-9F2B-5A91D5945A86Q39215322-11BA4CF8-8E9B-448D-A951-1D84E9D03EDFQ41254048-2B108943-B8D3-445F-98CD-FBAA1A930FC4Q41843748-F07A6AA7-FC79-4373-B7A7-DF73AC5A1777Q42148563-7B2A55C6-A31A-4E23-9017-7F979D138C43Q42795407-19F55298-9223-4013-98F8-AFCF00D203B3Q49436056-02B29193-375F-4315-B0B7-96AFB6DC5627Q58797890-9650FB17-0AF5-452C-80F1-1A3589D365C8
P2860
A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strains
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A novel sequence-based antigen ...... e selection of vaccine strains
@ast
A novel sequence-based antigen ...... e selection of vaccine strains
@en
type
label
A novel sequence-based antigen ...... e selection of vaccine strains
@ast
A novel sequence-based antigen ...... e selection of vaccine strains
@en
prefLabel
A novel sequence-based antigen ...... e selection of vaccine strains
@ast
A novel sequence-based antigen ...... e selection of vaccine strains
@en
P2860
P356
P1476
A novel sequence-based antigen ...... e selection of vaccine strains
@en
P2093
Krystina C Subieta
P2860
P304
P356
10.1093/PROTEIN/GZQ105
P577
2010-11-30T00:00:00Z